Evidence map›Paper›PMID 40265993›Full record

ArticleMovement disorders clinical practice2025

Cognitive Outcomes Following Second-Sided Focused Ultrasound Thalamotomy for Tremor.

Silina Z Boshmaf, Julie Petersen, Rohina Kumar, Nadia Scantlebury, Camryn R Rohringer, Alicia Triantafilou, Georgia Gopinath, Isabella J Sewell, Sarah-Mei Chen, Yuexi Huang and 8 more

Abstract read
In one paragraph

Article in Movement disorders clinical practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Silina Z BoshmafHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Julie PetersenRockefeller Neuroscience Institute, West Virginia University School of Medicine, Morgantown, West Virginia, USA.
Rohina KumarHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Nadia ScantleburyHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.ORCID https://orcid.org/0009-0001-8390-8393
Camryn R RohringerHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0002-1905-8611
Alicia TriantafilouHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Georgia GopinathHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Isabella J SewellHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Sarah-Mei ChenHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Yuexi HuangPhysical Sciences Platform, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Ryan M JonesPhysical Sciences Platform, Sunnybrook Research Institute, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0003-1541-4110
Benjamin LamHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Kullervo HynynenPhysical Sciences Platform, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Clement HamaniHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Michael L SchwartzHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Nir LipsmanHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Agessandro AbrahaoHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Jennifer S RabinHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0003-4754-2221

Funding

Harquail Centre for NeuromodulationThe Sandra Black Centre for Resilience & RecoveryUniversity of Toronto, Division of Neurology, Slamen-Fast New Initiatives
6 · The paper itself

Abstract

backgroundHistorically, staged bilateral thalamotomy has been associated with cognitive decline.

objectiveTo examine cognitive outcomes of second-sided focused ultrasound (FUS) thalamotomy in individuals with medication-refractory essential tremor (ET) who previously underwent unilateral FUS thalamotomy.

methodsTwenty-one individuals with medication-refractory ET completed cognitive testing before undergoing second-sided FUS thalamotomy and 4 months post-FUS. Cognitive changes were analyzed at the group and individual levels.

resultsAt the group level, no significant declines were observed on any of the test scores. At the individual level, most cognitive test scores remained stable (95% of scores), with declines (2% of scores) and improvements (3% of scores) occurring infrequently. Specifically, declines were observed on only four of the 19 cognitive test scores. No more than two participants declined on any single test score and no participant declined on more than two cognitive test scores.

conclusionsSecond-sided FUS thalamotomy is associated with minimal risk of cognitive decline.

Indexed as

CognitionCognitive DysfunctionEssential TremorThalamusAgedFemaleHumansMaleMiddle AgedNeuropsychological TestsTreatment Outcomecognitionessential tremorfocused ultrasoundthalamotomy

Identifiers

PMID40265993
PMCPMC12481419

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.